Linda C. Hogan, Head, Business Development and Strategy at CoLucid Pharmaceuticals, Inc. (CLCD), sold 1,862 shares at $28.52 ($53K) on 2016-11-07, disclosed to the SEC on 2016-11-07.
Scheduled sale ($53k) by Head, Business Development and Strategy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.95 | 185 | $5K | 10.1% |
| 2 | $28.52 | 1,677 | $48K | 89.9% |
| Total | $28.56 avg | 1,862 | $53K | 100% |
| Filing → |
| CLCD | SELL | 2016-11-01 | $22K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $96K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $969K | — | Filing → |